Participation burden can drive risks to the efficiency of a trial such as high drop-out rates, screen failures and protocol amendments. Identifying such risks during protocol design can help to avoid costly delays and enhance participation experience.
This self-assessment tool guides sponsors or patient organizations through a structured approach for rapid risk-assessment of participation burden for a specific clinical trial design. Risk mitigation strategies are provided for consideration.
Developed and validated by experts and easy to use whether patient-centricity is new or well established within your team.
The Fight Against Rare Diseases
Collectively, rare diseases represent a large medical challenge. While most have no cure, the appropriate treatment can greatly improve quality of…
Easing the Rare Disease Patient’s Burden in Clinical Trials with Innovative Technology
In this webinar, you will learn how technology can influence rare disease clinical study design, increase the speed of research and thereby reduce…
Patient-Centric Trial Development Toolkit
Learn more about our practical tools for sponsors, participants and champions of patient-centric trial development and how you can start using them…